Follow this preprint
Assessment of the impact of the new blister packaging of Biktarvy® (B/F/TAF) on treatment satisfaction of people living with HIV
JP Cruz, O Santos, M Rodrigues, R Morais, T Borralho, F Ferreira, View ORCID ProfileA Ferreira, J Albuquerque, P Nogueira, MP Silva, F Antunes
doi: https://doi.org/10.1101/2024.10.26.24316182
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
JP Cruz
1Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal
2iMed.ULisboa – Institute for Medicine Research, Faculdade de Farmácia, Universidade de Lisboa, Portugal
O Santos
3Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Portugal
4Unbreakable Idea Research, Painho, Portugal
M Rodrigues
1Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal
R Morais
1Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal
T Borralho
1Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal
F Ferreira
1Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal
A Ferreira
5BlueClinical – Investigação e Desenvolvimento em Saúde, Lda, Porto, Portugal
J Albuquerque
5BlueClinical – Investigação e Desenvolvimento em Saúde, Lda, Porto, Portugal
6Centro de Estatística e Aplicações, Faculdade de Ciências, Universidade de Lisboa, Portugal
P Nogueira
3Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Portugal
MP Silva
7Gilead Sciences, Lda, Lisboa, Portugal
F Antunes
3Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Portugal
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
Posted October 27, 2024.
Assessment of the impact of the new blister packaging of Biktarvy® (B/F/TAF) on treatment satisfaction of people living with HIV
JP Cruz, O Santos, M Rodrigues, R Morais, T Borralho, F Ferreira, A Ferreira, J Albuquerque, P Nogueira, MP Silva, F Antunes
medRxiv 2024.10.26.24316182; doi: https://doi.org/10.1101/2024.10.26.24316182
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (719)
- Anesthesia (214)
- Cardiovascular Medicine (3035)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12959)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4770)
- Geriatric Medicine (440)
- Health Economics (747)
- Health Informatics (3026)
- Health Policy (1095)
- Hematology (405)
- HIV/AIDS (951)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4544)
- Nursing (242)
- Nutrition (671)
- Oncology (2361)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (85)
- Pathology (512)
- Pediatrics (1229)
- Primary Care Research (515)
- Public and Global Health (7131)
- Radiology and Imaging (1586)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (503)
- Toxicology (63)
- Transplantation (218)
- Urology (187)